Poorer Clinical Outcomes in COVID-19 Driven by Comorbidities
In laboratory-confirmed cases of COVID-19, patients with any comorbidities have experienced poorer clinical outcomes compared with those without comorbidities.
In laboratory-confirmed cases of COVID-19, patients with any comorbidities have experienced poorer clinical outcomes compared with those without comorbidities.
Hepatitis B virus RNA in serum declines profoundly during treatment with pegylated interferon; therefore, early on-treatment HBV RNA levels may be used to predict nonresponse.
Although reinfection with HCV may occur following successful treatment in people with recent drug use, reinfection risk should not be used as a reason to withhold therapy from people with ongoing injecting drug use.
Modeled estimates can help guide policy and programs for prevention and treatment of HCV infection.
The seroprevalence of autoimmune hepatitis-related autoantibodies in patients with acute hepatitis E is elevated, particularly in women, and acute hepatitis E virus (HEV) infection may be related to autoimmune hepatitis, according to results of a study published in Emerging Microbes & Infections. Autoimmune hepatitis is a rare chronic inflammatory liver disease and although its etiology…
Although treating hepatitis C virus with direct-acting antivirals regimens has demonstrated numerous extrahepatic benefits, a significant benefit can be specifically attributed to a reduction in liver-related mortality.
Liver stiffness measurement value and the serum vitamin K absence or antagonist-II level may be significant predictors of HCC occurrence among patient with HBV-related cirrhosis.
Investigators sought to determine whether salvage treatment for NS5A-treatment failure is effective and well tolerated in chronic HCV genotype 4-infected patients, in both noncirrhotic and compensated cirrhotic groups.
The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis C genotype 4 with liver cirrhosis and advanced hepatic fibrosis who achieve sustained virologic response.
Pulmonary function test monitoring is recommended in pediatric patients with chronic hepatitis B.